| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,230,756 | 1,077,958 | 908,171 | 973,431 | | Cost of Revenue |
-
| (583,063) | 293,534 | 289,529 | | | Gross Profit | 1,230,756 | 1,661,021 | 614,637 | 683,902 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 814,458 | 1,297,570 | 357,561 | 378,926 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 35,347 | 37,265 | 33,754 | 36,612 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 384,722 | 326,186 | 223,322 | 268,364 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 119,196 | 84,060 | (43,265) | (81,493) | | Earnings Before Interest And Taxes | 503,804 | 414,131 | 180,057 | 186,871 | | Interest Expense | 268 | 211 | 2,092 | 1,200 | | Income Before Tax | 503,536 | 413,920 | 177,965 | 185,671 | | Income Tax Expense | 136,180 | 116,204 | 67,159 | 64,771 | | Minority Interest |
-
| 3,885 |
-
|
-
| | | | Net Income From Continuing Ops | 367,356 | 297,716 | 110,806 | 120,900 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 367,356 | 297,716 | 110,806 | 120,900 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $367,356 | $297,716 | $110,806 | $120,900 |
|
1.52% Nasdaq 0.00%
Income Statement
